Clinical Trial - Trial jRCT2021230019
Access comprehensive clinical trial information for jRCT2021230019 through Pure Global AI's free database. This phase not specified trial is sponsored by OHARA Pharmaceutical Co., Ltd. and is currently Recruiting. The study focuses on Parkinson's disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2021230019
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2021230019
Untitled Trial
Phase II clinical study of OP 2024 in advanced Parkinson's disease
Study Focus
Interventional
Sponsor & Location
OHARA Pharmaceutical Co., Ltd.
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Parkinson disease
Parkinsonism in diseases classified elsewhere
Dementia in Parkinson disease
Secondary parkinsonism
Postencephalitic parkinsonism
Data Source
Japan Registry Clinical Trial
jRCT2021230019
Non-Device Trial